Botulinum Toxin Injections
Effectiveness and safety of early intramuscular botulinum toxin injections to prevent shoulder deformity in babies with brachial plexus birth injury (POPB-TOX), a randomised controlled trial: study protocol
... of botulinum toxin injections (BTI) in the shoulder internal rotator muscles of 12-month-old babies in limiting the progression of posterior subluxation of the glenohumeral joint, compared with a ...
10
Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study
... Other critiques of this study include the effect of the learn- ing curve on the technique which may skew towards uni- lateral injections over the study period. The subjective nature of the decision of unilateral ...
11
Botulinum Toxin Injections for Simple Partial Motor Seizures Associated with Pain
... BTX-A injections into the frontotemporal muscles prior to inpatient monitoring to reduce muscle artifact and improve seizure localization using ...BTX injections were administered to the upper and lower ...
5
Selection process for botulinum toxin injections in patients with chronic-stage hemiplegic stroke: a qualitative study
... the injections (if there is a possibility of occurrence of side effects)”; thus, there was a conflict between the patient’s “expecta- tions of BT” and “hesitations about ...
11
Maximizing botulinum toxin injections for cosmetic and therapeutic applications with a single use, disposable, exact dose injection assist device
... the botulinum toxin injection pro- cedure is a begrudgingly accepted and universal fact of life even for experienced injectors, as confirmed in this ...
12
Botulinum toxin injections for the treatment of frontal tension headache
... receive injections with saline or botulinum toxin type ...or botulinum toxin type A treatment and that physician blindly picked a patient when that patient was scheduled for an ...
7
Botulinum toxin injections for blepharospasm prior to ocular surgeries
... the injections were more evident on the 14th day and that the level of decrease in the blepharospasm degree and eyelid power was sufficient to let the eye speculum to be ...
5
Botulinum Toxin Injections or Application of Splints: Impact on Spasticity, Range of Motion and Function of Upper Extremity in Chronic Stroke Patients
... or botulinum toxin injection on spasticity, range of motion and upper extremity function in a 3- month ...or botulinum toxin injection and they were followed up about 3 ...of botulinum ...
6
The impact of botulinum toxin injections in adductor spasmodic dysphonia: A cross sectional and longitudinal study
... When examining changes over time, the results o f the present study showed that the two coping groups, identified by cluster analysis, did not change their coping responses over time. A possible explanation for using ...
238
Early experimental results of using a novel delivery carrier, Hyaluronan-phosphatidylethanolamine (HA-PE) which may allow simple bladder instillation of Botulinum Toxin A as effectively as direct detrusor muscle injection.
... Oral anti-muscarinic agents have been widely used as first-line treatment for patients with DO. Failure of adequate anti-muscarinic therapy, may require surgical intervention designed to reduce bladder storage pressures ...
107
Gastroparesis: a review of current and emerging treatment options
... Abstract: Gastroparesis is a motility disorder of the stomach causing delay in food emptying from the stomach without any evidence of mechanical obstruction. The majority of cases are idiopathic. Patients need to be ...
5
Vocal aging and adductor spasmodic dysphonia: Response to botulinum toxin injection
... of botulinum toxin injection and our expectations for its ...using botulinum toxin injections of the vocal folds in order to suppress adductory muscle spasms which are disruptive to ...
22
Medical treatment of dystonia
... 5-HTP: 5-hydroxytryptophan; AAN: American Academy of Neurology; ACh: Acetylcholine; BH 4 : Tetrahydrobiopterin; BoNT: Botulinum toxin injections; ChI: Cholinergic interneuron; DBPC: Doub[r] ...
18
The phenomenology and treatment of idiopathic adult-onset truncal dystonia: a retrospective review
... Results: The mean age of onset of idiopathic truncal dystonia was 47.6 years old and the majority of patients were male. Truncal flexion was the most common direction of dystonic movement and the dystonia was most ...
6
Botulinum toxin type A injections for the management of muscle tightness following total hip arthroplasty: a case series
... utilized botulinum toxin injections in orthopaedic patients ...the botulinum toxin was utilized as a substitute for tenotomy to attenuate the function of the triceps surae muscle ...
7
Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment
... To evaluate possible influences of prior treatment on the success rates of endoscopic botulinum toxin injections, a subgroup analysis in consecutively treated achalasia pa- tients was carried out in ...
8
Responsiveness of the Functional Mobility Scale for children with cerebral palsy
... and botulinum toxin group were isolated and analysed separately to examine change versus relative stability in mobility ...have botulinum toxin does not change significantly and these children ...
9
Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence
... of botulinum toxin studies were "botulinum A toxin overactive bladder," sacral neu- romodulation were "sacral neuromodulation overactive bladder," and surgical treatment ...
10
Improvement of chronic facial pain and facial dyskinesia with the help of botulinum toxin application
... the toxin as well as a normalization of increased muscle spindle activity, decompression of afferent nocice- ptive neurons of muscular and vascular tissue, retrograde intake of botulinum toxin in the ...
5
Efficacy of Botulinum Toxin Type A in Trigeminal Neuralgia in a South Asian Cohort.
... 28. Silberstein SD, Stark SR, Lucas SM, Christie SN, Degryse RE, Turkel CC, et al. Botulinum toxin type A for the prophylactic treatment of chronic daily headache: A randomized, double‑blind, ...
6